<table id="_RefID0EHSBG" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 3. Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin</caption>
<col width="40%"></col>
<col width="19%"></col>
<col width="20%"></col>
<col width="21%"></col>
<thead>
<tr>
<th align="left" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<content stylecode="bold"> Co-administered drug and dosing regimen</content>
</th>
<th align="center" colspan="3" stylecode="Rrule Botrule Toprule " valign="top">
<content stylecode="bold"> Atorvastatin</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Rrule Lrule Toprule ">
<paragraph> </paragraph>
</td>
<td stylecode="Rrule Toprule ">
<paragraph> <content stylecode="bold">Dose (mg)</content>
</paragraph>
</td>
<td stylecode="Rrule Toprule ">
<paragraph> <content stylecode="bold">Change in AUC</content>
<footnote id="_RefFOOT_6885">Data given as x-fold change represent a simple ratio between co-administration and atorvastatin alone (i.e., 1-fold = no change). Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change).</footnote>
</paragraph>
</td>
<td stylecode="Rrule Toprule ">
<paragraph> <content stylecode="bold">Change in Cmax</content>
<footnoteref idref="_RefFOOT_6885"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnote id="_RefFOOT_6886">See Sections <linkhtml href="#LINK_3956bb0c-6a95-42b9-9aff-4bb68e4d60d7">5.1</linkhtml> and <linkhtml href="#LINK_09afeb80-62ca-41cb-9a72-299e838642c3">7</linkhtml> for clinical significance.</footnote> Cyclosporine 5.2 mg/kg/day, stable dose</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 8.7 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑10.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Tipranavir 500 mg BID/ ritonavir 200 mg BID, 7 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 9.4 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 8.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Telaprevir 750 mg q8h, 10 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 20 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 7.88 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 10.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref>
<sup>,</sup>
<footnote id="_RefFOOT_6887">The dose of saquinavir plus ritonavir in this study is not the clinically used dose. The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study.  Therefore, caution should be applied and the lowest dose necessary should be used.</footnote> Saquinavir 400 mg BID/ ritonavir 400mg BID, 15 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 3.9 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 4.3 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Clarithromycin 500 mg BID, 9 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 80 mg QD for 8 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 4.4 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 5.4 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 3.4 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.25 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Itraconazole 200 mg QD, 4 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 3.3 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 20%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Fosamprenavir 700 mg BID/ ritonavir 100 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.53 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.84 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Fosamprenavir 1400 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.3 fold</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 4.04 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Nelfinavir 1250 mg BID, 14 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 74%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.2 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Grapefruit Juice, 240 mL QD <footnote id="_RefFOOT_6888">Greater increases in AUC (up to 2.5 fold) and/or Cmax (up to 71%) have been reported with excessive grapefruit consumption (≥ 750 mL - 1.2 liters per day).</footnote>
</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 37%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 16%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Diltiazem 240 mg QD, 28 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 51%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> No change</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Erythromycin 500 mg QID, 7 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 33%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 38%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Amlodipine 10 mg, single dose</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 80 mg, SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 15%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 12 %</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Cimetidine 300 mg QD, 2 weeks</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 2 weeks</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ Less than 1%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 11%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Colestipol 10 mg BID, 28 weeks</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg QD for 28 weeks</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> Not determined</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 26%<footnote id="_RefFOOT_6889">Single sample taken 8-16 h post dose.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Maalox TC® 30 mL QD, 17 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg QD for 15 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 33%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 34%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> Efavirenz 600 mg QD, 14 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 10 mg for 3 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 41%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Rifampin 600 mg QD, 7 days (co-administered) <footnote id="_RefFOOT_6890">Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations.</footnote>
</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 30%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Rifampin 600 mg QD, 5 days (doses separated) <footnoteref idref="_RefFOOT_6890"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 80%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ 40%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Gemfibrozil 600 mg BID, 7 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 35%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↓ Less than 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph> <footnoteref idref="_RefFOOT_6886"></footnoteref> Fenofibrate 160 mg QD, 7 days</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> 40 mg SD</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 3%</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph> ↑ 2%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph> Boceprevir 800 mg TID, 7 days </paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph> 40 mg SD </paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph> ↑ 2.30 fold</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph> ↑ 2.66 fold</paragraph>
</td>
</tr>
</tbody>
</table>